Certificate of Analysis
Purity
≥98.0%
Method
HPLC / MS
Testing
Third-Party
COA Status
Available
cagrilintide 2.5mg+Semaglutide2.5mg
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Choose Pack Size
Quantity
Research Use Only — All products are intended strictly for laboratory research purposes and are not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
About cagrilintide 2.5mg+Semaglutide2.5mg
This research formulation combines cagrilintide (AM833; 2.5 mg) — a long-acting amylin analog — and semaglutide (NNC-0177-0864; 2.5 mg) — a GLP-1 receptor agonist — in a single lyophilized vial. Cagrilintide activates amylin receptors (AMY1–AMY3 subtypes formed by CRLR/RAMP complexes), while semaglutide engages the GLP-1 receptor, resulting in a dual-mechanism formulation that targets two distinct incretin-related receptor systems simultaneously.
The combination has been studied in controlled research settings to investigate the pharmacodynamic interactions between amylinergic and GLP-1-ergic signaling pathways, including combined downstream cAMP signaling profiles, complementary receptor occupancy dynamics, and comparative in vitro potency measurements. This formulation is used as a research reference compound in laboratory investigations of dual incretin/amylin receptor pharmacology and is intended solely for qualified researchers conducting preclinical or in vitro studies.
Formulation Information
| Property | Value |
|---|---|
| Molecular Formula | Multi-component blend |
| Molecular Weight | Cagrilintide: ~3,907.4 g/mol | Semaglutide: 4,113.6 g/mol |
| CAS Number | N/A — Research Blend |
| Synonyms | CagriSema (research reference), Amylin/GLP-1 Dual Agonist Blend |
99%+
PURITY
Third Party Tested
Independently verified by ISO-accredited laboratories. Batch-specific COAs available on request.
GMP
CERT.
GMP Manufacturing Standards
Synthesized in registered facilities following Good Manufacturing Practices with full chain-of-custody documentation.
FAST
SHIP
Best in Class Fulfillment
Same-day fulfillment on qualifying orders. Secure cold-chain packaging. Domestic and international research shipping.
ZERO
FILLERS
Zero Fillers or Additives
Pure active compounds only. Lyophilized without fillers or preservatives. Composition independently verified.
Scientific Content Review
All technical product descriptions, molecular data, and research context on this page have been prepared with reference to published scientific literature and PubChem compound databases. Content is intended for informational purposes in a research catalog context and does not constitute medical advice or claim therapeutic efficacy.
cagrilintide 2.5mg+Semaglutide2.5mg is a research compound available for controlled laboratory investigation and scientific study. This product is intended strictly for in vitro research, preclinical investigation, and analytical characterization by qualified researchers. Not for human consumption.
Category
GLP-1 / Metabolic
Purity
≥98.0%
Available Sizes
5MG
COA
Available